Randomised trial of eradication of Helicobacter pylori before nonsteroidal anti-inflammatory drug therapy to prevent peptic ulcers

Lancet

Volumn 350, Issue 9083, 1997, Pages 975-979

  Chan, Francis K L ^a   Sung, Joseph J Y ^a   Chung, S C Sydney ^a   To, K F ^a   Yung, M Y ^a   Leung, Vincent K S ^a   Lee, Y T ^a   Chan, Cynthia S Y ^b   Li, Edmund K M ^a   Woo, Jean ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BISMUTH CITRATE; METRONIDAZOLE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; TETRACYCLINE;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUODENUM ULCER; DYSPEPSIA; ENDOSCOPY; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PEPTIC ULCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH ULCER;

EID: 0030813408     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)04523-6     Document Type: Article

References (28)

1. Langman MJS. Anti-inflammatory drugs and the gut-ulcerative damage and protection from cancer. Excerpta Medica. 1995; 72: 1-8.
2. Fries JF, Williams CA, Bloch DA, Michel BA. Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factors model. Am J Med 1991; 91: 213-22.
3. Langman MJS, Weil J, Wainwright P, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 1075-78.
4. Hawkey CJ. Non-steroidal anti-inflammatory drug gastropathy: causes and treatment. Scand J Gastroenterol 1996; 31 (suppl 220): 124-27.
5. Gabriel SE, Jaakkimainen L, Bombardier C. Risks for serious gastrointestinal complications related to the use of non-steroidal anti-inflammatory drugs: a meta-analysis. Ann Intern Med 1991; 115: 787-96.
6. Somerville K, Faulkner G, Langman MJS. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986; i: 452-54.
7. Bloom BS. Direct medical costs of disease and gastrointestinal side effects during treatment of arthritis. Am J Med 1984; 84 (suppl 2A): 20-24.
8. Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal antiinflammatory drugs: a randomized, double-blind, placebo-controlled trial. Am Intern Med 1995; 123: 241-49.
9. Taha AS, Hudson N, Hawkey CJ, et al. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N Engl J Med 1996; 334: 1435-39.
10. Ekstrom P, Carling L, Wetterhus S, et al. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy: a Nordic multicentre study. Scand J Gastroenterol 1996; 31: 753-58.
11. Levine JS. Misoprostol and nonsteroidal anti-inflammatory drugs: a tale of effects, outcomes, and costs. Ann Intern Med 1995; 123: 309-10.
12. Taha AS, Nakshabendi I, Lee FD, Sturrock RD, Russell RI. Chemical gastritis and Helicobacter pylori related gastritis in patients receiving non-steroidal anti-inflammatory drugs: comparison and correlation with peptic ulceration. J Clin Pathol 1992; 45: 135-39.
13. Heresbach D, Raoul JL, Bretagne JF, et al. Helicobacter pylori: a risk and severity factor of non-steroidal anti-inflammatory drug induced gastropathy. Gut 1992; 33: 1608-11.
14. Upadhyay R, Howatson A, McKinlay A, Danesh BJZ, Sturrock RD, Russell RI. Campylobacter pylori associated gastritis in patients taking non-steroidal anti-inflammatory drugs. Br J Rheumatol 1988; 27: 113-16.
15. Graham DY, Lidsky MD, Cox AM, et al. Long-term non-steroidal antiinflammatory drug use and Helicobacter pylori infection. Gastroenterology 1991; 100: 1653-57.
16. Martin DF, Montgomery E, Dobek AS, Patrissi GA, Peura DA. Campylobacter pylori NSAIDs, and smoking: risk factors for peptic ulcer disease. Am J Gastroenterol 1989; 84: 1268-72.
17. Shallcross TM, Rathbone BJ, Wyatt JI, Heatley RV. Helicobacter pylori associated chronic gastritis and peptic ulceration in patients taking non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 1990; 4: 515-22.
18. Loeb DS, Talley NJ, Ahlquist DA, Carpenter HA, Zinsmeister AR. Long-term non-steroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori. Gastroenetrology 1992; 102: 1899-905.
19. Li EKM, Sung JY, Suen R, et al. Helicobacter pylori infection increases the risk of peptic ulcers in chronic users in chronic of non-steroidal anti-inflammatory drugs. Scand J Rheumatol 1996; 25: 42-46.
20. Publig W, Wustinger C, Zandl C. Non-steroidal anti-inflammatory drugs (NSAIDs) cause gastrointestinal ulcers mainly in Helicobacter pylori carriers. Wien Klin Wochenschr 1994; 106: 276-79.
21. Lanza FL, Evans DG, Graham DY. Effect of Helicobacter pylori infection on the severity of gastroduodenal mucosal injury after acute administration of naproxen or aspirin to normal volunteers. Am J Gastroenterol 1991; 86: 735-37.
22. Thillainayagam AV, tabaqchali S, warrington SJ, Farthing MJG. Interrelationships between Helicobacter pylori infection, non-steroidal anti-inflammatory drugs and gastroduodenal disease: a prospective study in healthy volunteers. Dig Dis Sci 1994; 39: 1085-89.
23. Laine L, Cominelli F, Sloane R, Casini-Raggi V, Marin-Sorensen M, Weinstein WM. Interaction of NSAIDs and Helicobacter pylori on gastroduodenal injury and prostaglandin production: a controlled double-blind trial. Ailment Pharmacol Ther 1995; 9: 127-35.
24. Goggin PM, Collins DA, Jazrawi RP, et al. Prevalence of Helicobacter pylori infection and its effects on symptoms and non-steroidal anti-inflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis. Gut 1993; 34: 1677-80.
25. Kim JG, Graham DY, The Misoprostol Study group. Helicobacter pylori infection and the development of gastric or duodenal ulcer in arthritic patients receiving chronic NSAID therapy. Am J Gastroenterol 1994; 89: 203-07.
26. Taha AS, Sturrock RD, Russell RI. Mucosal erosions in longterm non-steroidal anti-inflammatory drug users: predisposition to ulceration and relatiom to Helicobacter pylori. Gut 1995; 36: 334-36.
27. Seppala K, Pikkarainen P, Sipponen P, Kivilaakso E, Gormsen MH, and the Finnish Gastric Ulcer Study Group. Cure of peptic ulcer associated with eradication of Helicobacter pylori. Gut 1995; 36: 834-37.
28. Bianchi Porro G, Parente F, Imbesi V, Montrone F, Caruso I. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users: response to omeprazole dual therapy. Gut 1996; 59: 22-26.